Isolated anti-HBc: reflections from clinical microbiology and infectious diseases

Affiliations

¹ MD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Experimental Infections Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
² MD, PhD, Infectious Diseases Unit, Ospedale Policlinico San Martino-IRCC, 16132 Genoa, Italy.
³ MD, PhD, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headington, Oxford OX3 9DU, UK and Division of Medical Virology, Stellenbosch University, Stellenbosch, South Africa.
⁴ MD, PhD, Microbiology and Immunology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
⁵ MD, PhD, Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan and Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
⁶ MD, PhD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.

Editorial

Hanna Rydén et al. Germs. 2022.

. 2022 Jun 30;12(2):155-157.

doi: 10.18683/germs.2022.1318. eCollection 2022 Jun.

¹ MD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Experimental Infections Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
² MD, PhD, Infectious Diseases Unit, Ospedale Policlinico San Martino-IRCC, 16132 Genoa, Italy.
³ MD, PhD, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headington, Oxford OX3 9DU, UK and Division of Medical Virology, Stellenbosch University, Stellenbosch, South Africa.
⁴ MD, PhD, Microbiology and Immunology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
⁵ MD, PhD, Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan and Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
⁶ MD, PhD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.

No abstract available

Conflict of interest statement

Conflicts of interest: MIA has received research funding from Pfizer, Janssen and Prenetics. The remaining authors declare no conflicts of interest.

1. Moretto F, Catherine FX, Esteve C, Blot M, Piroth L. Isolated anti-HBc: significance and management. J Clin Med. 2020;9:202. doi: 10.3390/jcm9010202. - DOI - PMC - PubMed
1. Kang SY, Kim MH, Lee WI. The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol. 2010;82:1508–14. doi: 10.1002/jmv.21862. - DOI - PubMed
1. Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT, American Gastroenterological Association Institute American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148:215–9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. - DOI - PubMed
1. European Association for the Study of the Liver EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–98. doi: 10.1016/j.jhep.2017.03.021. - DOI - PubMed
1. Seto WK, Chan TS, Hwang YY, et al. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: a prospective study. Hepatology. 2017;65:1451–61. doi: 10.1002/hep.29022. - DOI - PubMed